copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
LFB | Our passion:u0003Bringing bioinnovation to patients LFB USA is a globalized company which develops and provides pharmaceutical bioproducts through its innovative technologies for patients with serious diseases LFB USA is committed to overcoming barriers through purposeful science to improve people’s lives
About the Company | LFB LFB USA is a company within the LFB Group, a leading European biopharmaceutical company specialized in innovative biotherapies, marketing its medicinal products around the world
Mission and Values | LFB At LFB USA, we are powering the development and commercialization of highly innovative recombinant therapies to address an ever-growing set of unmet medical needs To do this effectively, we challenge ourselves to think differently and to confront challenges with a focused determination Our deep appreciation for and understanding of science is paramount But of equal importance is our
Early Stage Products | LFB Research Projects Led Within LFB USA The proprietary rPRO Technology™ that drives LFB S A 's product development enables production of innovative recombinant therapies that are more cost-effective and scalable compared to traditionally produced recombinant therapeutics The company’s efforts are focused on developing biosimilars and next-generation biobetter therapeutics that address the
LFBs Pipeline | LFB LFB USA’s role developing new biotherapies in the US LFB USA has a key role in developing LFB's pipeline in the US, focusing on research, clinical development and regulatory strategies and filings For the Factor FVIIa (LR769) program, LFB USA handles the upstream manufacture of the protein and the clinical and regulatory aspects
Leadership | LFB Leadership LFB USA is led by a team of business experts and scientists with a successful track record of developing and commercializing important and highly innovative healthcare technologies and life-changing therapeutics
News Releases | LFB LFB completes the sale of CELL for CURE to Novartis The completion of the sale comes as part of LFB’s strategy to refocus on its core business – medicinal products derived from plasma or recombinant proteins Les Ulis (France), 1st April 2019 – LFB announces the completion of the sale of CELLforCURE to Novartis
Therapeutic Proteins for Serious and Rare Diseases | LFB Within the LFB Group, which is a leader in the field of therapeutic proteins in France, LFB USA enables the production of life-saving medicines within the Group’s key areas of expertise and focus – immunology, intensive care and hemostasis By providing development, manufacturing, quality control, quality assurance, clinical and regulatory capabilities and services, LFB USA is cultivating
FDA Approves Additional Treatment for Adults and Adolescents . . . - LFB USA April 1st, 2020 The U S Food and Drug Administration today approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors (neutralizing antibodies) Sevenfact contains an active ingredient expressed in genetically engineered rabbits
Clinical Trials | LFB Clinical Trials LFB USA is focused on developing and commercializing life-changing and life-saving therapies for patients, particularly in the area of rare diseases We’re committed to reaching more patients with innovative treatments and making a positive impact across more markets and therapeutic areas